Reirradiation and Niraparib in Patients With Recurrent Glioblastoma

NCT05666349 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funder support withdrawn 13-Oct-2023. Study did not open to recruitment.

Conditions

Recurrent Glioblastoma

Interventions

DRUG: Niraparib
RADIATION: Re-irradiation (re-RT)

Sponsor

University College, London

Collaborators

[object Object]